Maria Luisa Biondi

About Diatech Pharmacogenetics

This author has not yet filled in any details.
So far Diatech Pharmacogenetics has created 1080 blog entries.

11 03, 2022

IVDR CERTIFICATION: WE GOT IT!
IVDR CERTIFICATION: WE GOT IT!

News

IVDR CERTIFICATION: WE GOT IT!

Diatech Pharmacogenetics2022-03-11T16:02:51+01:00

23 02, 2022

Monthly focus on regulatory status of new targeted therapies in oncology- January 2022

Diatech Pharmacogenetics2022-04-12T17:30:48+02:00

26 01, 2022

Monthly focus on regulatory status of new targeted therapies in oncology- December 2021

Diatech Pharmacogenetics2022-01-27T17:29:30+01:00

21 12, 2021

Happy Holidays 2021!
Happy Holidays 2021!

News

Happy Holidays 2021!

Diatech Pharmacogenetics2021-12-21T18:21:09+01:00

21 12, 2021

Shooting Cancer – Highlights Monthly focus on regulatory status of new targeted therapies in oncology – November 2021

Diatech Pharmacogenetics2021-12-21T17:17:52+01:00

7 12, 2021

We are pleased to report that the Easy Sars COV-2 Kit code RT020-WE can detect the new viral variant defined as Omicron
We are pleased to report that the Easy Sars COV-2 Kit code RT020-WE can detect the new viral variant defined as Omicron

News

We are pleased to report that the Easy Sars COV-2 Kit code RT020-WE can detect the new viral variant defined as Omicron

Diatech Pharmacogenetics2021-12-07T17:15:12+01:00

9 11, 2021

NTRK inhibitors, a successful example of a tissue-agnostic approach in anticancer targeted therapy

Diatech Pharmacogenetics2021-11-11T17:46:37+01:00

3 11, 2021

Caterina De Luca et. al., RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer.

Diatech Pharmacogenetics2021-11-03T17:22:10+01:00

Previous 123 Next